Standards › ASF Health Standards v10 › Standard 43
Standard 43
Organ and Tissue Transplant
Organ and tissue transplant: independent donor consent, transparent allocation, no financial incentive, recipient evaluation, end-to-end traceability and post-transplant follow-up..
Each criterion is shown in three settings: Humanitarian settings, Transition and fragile, and Standard. In standard settings, every criterion is Must.
Training colours: red means essential, green recommended, yellow optional. Each course shows its level for each setting: humanitarian, transition and fragile, and standard.
43.1Donor Consent Obtained Through a Process Independent of the Transplant TeamHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Donor or donor-family consent for organ or tissue donation is obtained through a process independent of the transplant team requesting the organ, with the independence structurally built in — not a theoretical separation undermined by the same staff being involved in both roles.
Why it matters. Donation must be a free choice, made by the donor or their family, and not pressured by the team that will use the organ. A consent process separate from the treatment team protects that choice.
How the surveyor verifies this criterion
Sample. Review donor consent records for all donations in the last 12 months.
1. Donor or family consent is obtained by a process independent of the transplant team.
Method. Check each consent for the person who took it and their role in the transplant team.
Evidence to show. Donor consent independent of the transplant team (TXP-POL-001).
Pass when. No consent was taken by a member of the requesting transplant team.
2. Consent is recorded with the donor’s known wishes or the family’s decision.
Method. Check each consent record for the wishes or decision recorded.
Evidence to show. Donor consent record (TXP-FRM-001).
Pass when. Every consent records the wishes or decision.
Immediate fail (any one means the criterion is not met). The transplant surgeon who needs the organ asks the family for consent.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Donor consent independent of the transplant team | Must |
| Nurse (ISCO 2221) | Completes the Donor consent record | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| TXP-FRM-001 · Donor consent record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
| TXP-POL-001 · Donor consent independent of the transplant team | Chief executive (ISCO 1120) | Governing body members | N/A | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Healthcare Ethics for ASF Accreditation (A-07) | Manager; Nurse |
References
- WHO (2025). Guiding Principles on Human Cell, Tissue and Organ Transplantation. Used for: Guiding principles for human cell, tissue and organ transplantation: donor consent, independent consent process, allocation, payment, traceability, recipient evaluation and follow-up. https://news.gmj.ge/guideline/guiding-principles-on-human-cell-tissue-and-organ-transplantation/
43.2Organ Allocation Follows a Transparent, Documented ProtocolHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Organ allocation decisions follow a written, transparent protocol based on clinical criteria, applied consistently, with any deviation from the standard protocol specifically documented and justified — not informal decisions vulnerable to undue influence.
Why it matters. Organs are scarce. Allocating them by a written, transparent rule, based on clinical need, is the only fair way to decide who receives one.
How the surveyor verifies this criterion
Sample. Review organ allocation decisions for the last 12 months, including any decision that departed from the protocol.
1. Allocation follows the written protocol and its clinical criteria.
Method. Check each allocation against the protocol criteria.
Evidence to show. Organ allocation protocol (TXP-POL-002).
Pass when. Every allocation follows the protocol criteria.
2. Each allocation is recorded with the criteria used.
Method. Check each allocation record for the criteria and the date.
Evidence to show. Allocation decision register (TXP-REG-001).
Pass when. Every allocation records the criteria used.
3. Any departure from the protocol is recorded with the reason and reviewed.
Method. Check each departure for the reason and the review.
Evidence to show. Allocation decision register (TXP-REG-001).
Pass when. Every departure has a reason and a review.
Immediate fail (any one means the criterion is not met). A kidney allocated to a friend of a senior clinician with no criteria recorded.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Organ allocation protocol | Must |
| Secretary (ISCO 3344) | Keeps the Allocation decision register | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| TXP-REG-001 · Allocation decision register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
| TXP-POL-002 · Organ allocation protocol | Chief executive (ISCO 1120) | Governing body members | N/A | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Healthcare Ethics for ASF Accreditation (A-07) | Manager; Nurse |
References
- WHO (2025). Guiding Principles on Human Cell, Tissue and Organ Transplantation. Used for: Guiding principles for human cell, tissue and organ transplantation: donor consent, independent consent process, allocation, payment, traceability, recipient evaluation and follow-up. https://news.gmj.ge/guideline/guiding-principles-on-human-cell-tissue-and-organ-transplantation/
43.3No Financial Incentive to Donor or FamilyHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
No financial payment or material incentive, beyond legitimate reimbursement of documented direct costs, is offered to a donor or donor family in connection with organ or tissue donation, with staff trained to recognise and refuse any such arrangement.
Why it matters. Paying a donor or their family for an organ is exploitation and is banned in most places. Only legitimate costs, such as travel, may be covered, and only with a record.
How the surveyor verifies this criterion
Sample. Review all payments and reimbursements linked to donation for the last 12 months.
1. No payment or incentive is offered to a donor or donor family.
Method. Check the payment log for any payment to a donor or family.
Evidence to show. No financial incentive (TXP-POL-003).
Pass when. No sampled payment is an incentive.
2. Each reimbursement is for a documented direct cost.
Method. Check each reimbursement for the receipt and the cost category.
Evidence to show. Payments and reimbursement register (TXP-REG-002).
Pass when. Every reimbursement has a receipt and a documented direct cost.
3. Each reimbursement is approved before payment.
Method. Check each reimbursement for the approval before the payment date.
Evidence to show. Payments and reimbursement register (TXP-REG-002).
Pass when. Every reimbursement was approved before payment.
Immediate fail (any one means the criterion is not met). A family paid for the donor’s funeral costs as a reward for donation, with no receipt.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the No financial incentive | Must |
| Secretary (ISCO 3344) | Keeps the Payments and reimbursement register | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| TXP-REG-002 · Payments and reimbursement register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
| TXP-POL-003 · No financial incentive | Chief executive (ISCO 1120) | Governing body members | N/A | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Healthcare Ethics for ASF Accreditation (A-07) | Manager; Nurse |
References
- WHO (2025). Guiding Principles on Human Cell, Tissue and Organ Transplantation. Used for: Guiding principles for human cell, tissue and organ transplantation: donor consent, independent consent process, allocation, payment, traceability, recipient evaluation and follow-up. https://news.gmj.ge/guideline/guiding-principles-on-human-cell-tissue-and-organ-transplantation/
43.4Recipient Evaluation and Informed Consent ProcessHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Transplant recipients undergo a documented evaluation against clinical eligibility criteria, with informed consent covering realistic outcomes, risks, and the source of the organ or tissue where legally and clinically relevant — not a general surgical consent treated as sufficient.
Why it matters. A transplant recipient must be fit for the procedure and understand its risks. A documented evaluation and informed consent make sure the decision is sound.
How the surveyor verifies this criterion
Sample. Review evaluation and consent records for 15 transplant recipients.
1. Each recipient is evaluated against documented clinical eligibility criteria.
Method. Check each evaluation for the criteria checked and the outcome.
Evidence to show. Recipient evaluation and consent (TXP-SOP-001).
Pass when. Every recipient has a documented evaluation.
2. Consent covers realistic outcomes, risks and alternatives.
Method. Check each consent for the three elements.
Evidence to show. Recipient evaluation and consent record (TXP-FRM-002).
Pass when. Every consent covers all three elements.
Immediate fail (any one means the criterion is not met). A recipient listed for transplant with no documented evaluation and no consent discussion of risks.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Recipient evaluation and consent | Medium |
| Nurse (ISCO 2221) | Completes the Recipient evaluation and consent record | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| TXP-SOP-001 · Recipient evaluation and consent | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| TXP-FRM-002 · Recipient evaluation and consent record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Transplant Recipient Evaluation and Informed Consent (TXP-01) | Manager; Nurse |
References
- WHO (2025). Guiding Principles on Human Cell, Tissue and Organ Transplantation. Used for: Guiding principles for human cell, tissue and organ transplantation: donor consent, independent consent process, allocation, payment, traceability, recipient evaluation and follow-up. https://news.gmj.ge/guideline/guiding-principles-on-human-cell-tissue-and-organ-transplantation/
43.5Organ and Tissue Traceability, End to EndHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Every organ or tissue is traceable through a documented chain of custody from donor to recipient, including handling, testing, and transport, with no gap in the record at any point in that chain.
Why it matters. An organ or tissue must be traceable from donor to recipient, through every step of handling, testing and transport. Without a chain of custody, an unsafe donation cannot be found or stopped.
How the surveyor verifies this criterion
Sample. Review chain of custody records for 15 organ or tissue donations from donor to recipient.
1. Handling, testing and transport are recorded at each step.
Method. Check each record for the handling, testing and transport entries.
Evidence to show. Organ handling and transport record (TXP-FRM-003).
Pass when. Every step is recorded with time and person.
Immediate fail (any one means the criterion is not met). A donor organ arrives with no label and no record of transport temperature.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Nurse (ISCO 2221) | Completes the Organ handling and transport record | Medium |
| Manager (ISCO 1342) | Checks the criterion at each review | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| TXP-FRM-003 · Organ handling and transport record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Organ and Tissue Traceability End to End (TXP-02) | Manager; Nurse |
References
- WHO (2025). Guiding Principles on Human Cell, Tissue and Organ Transplantation. Used for: Guiding principles for human cell, tissue and organ transplantation: donor consent, independent consent process, allocation, payment, traceability, recipient evaluation and follow-up. https://news.gmj.ge/guideline/guiding-principles-on-human-cell-tissue-and-organ-transplantation/
43.6Post-Transplant Follow-Up and Outcome TrackingHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Transplant recipients are followed systematically after the procedure, with graft and patient outcomes tracked and reported, not lost to follow-up once the recipient is discharged from the immediate post-operative period.
Why it matters. After a transplant, the graft and the patient must be followed for years. Tracking outcomes shows whether the service is succeeding, and catches problems early.
How the surveyor verifies this criterion
Sample. Review follow-up records for all recipients transplanted in the last 2 years.
1. Each recipient is followed up at the defined schedule.
Method. Check each recipient record for the follow-up visits against the schedule.
Evidence to show. Post-transplant follow-up and outcome tracking (TXP-SOP-003).
Pass when. Every recipient is followed up on schedule.
2. Graft and patient outcomes are recorded and reported.
Method. Check the outcome register for each recipient and the report.
Evidence to show. Graft and patient outcome register (TXP-REG-004).
Pass when. Every recipient has outcomes recorded and reported.
3. Recipients lost to follow-up are traced.
Method. Check each recipient lost to follow-up for the tracing attempts.
Evidence to show. Post-transplant follow-up and outcome tracking (TXP-SOP-003).
Pass when. Every recipient lost to follow-up has tracing attempts recorded.
Immediate fail (any one means the criterion is not met). A recipient discharged after transplant and lost to follow-up within six months.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Post-transplant follow-up and outcome tracking | Medium |
| Secretary (ISCO 3344) | Keeps the Graft and patient outcome register | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| TXP-SOP-003 · Post-transplant follow-up and outcome tracking | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| TXP-REG-004 · Graft and patient outcome register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Post-Transplant Follow-Up and Outcome Tracking (TXP-03) | Manager; Nurse |
References
- WHO (2025). Guiding Principles on Human Cell, Tissue and Organ Transplantation. Used for: Guiding principles for human cell, tissue and organ transplantation: donor consent, independent consent process, allocation, payment, traceability, recipient evaluation and follow-up. https://news.gmj.ge/guideline/guiding-principles-on-human-cell-tissue-and-organ-transplantation/
Who is responsible for Standard 43
Each criterion names the positions responsible for it. Every position links to its own terms of reference.
| Criterion | Responsible | Supports |
|---|---|---|
| 43.1 Donor Consent Obtained Through a Process Independent of the Transplant Team | Ethics committee secretary Legal counsel |
Consultant physician (internal medicine) |
| 43.2 Organ Allocation Follows a Transparent, Documented Protocol | Ethics committee secretary Consultant physician (internal medicine) |
Legal counsel |
| 43.3 No Financial Incentive to Donor or Family | Chief financial officer (CFO) Legal counsel |
Accountant |
| 43.4 Recipient Evaluation and Informed Consent Process | Consultant physician (internal medicine) Legal counsel |
Social worker |
| 43.5 Organ and Tissue Traceability, End to End | Head of laboratory Risk manager |
Medical laboratory scientist |
| 43.6 Post-Transplant Follow-Up and Outcome Tracking | Consultant physician (internal medicine) Clinical audit officer |
Quality manager |
Role details: reporting, supervision and training
Training shown is the general recommendation. Role-specific training is set in the next improvement round.
Questions and answers
The criterion text is the authority. These answers summarise it.
Who does Standard 13 apply to?
Hospitals and transplant services that take, allocate or transplant organs and tissues, including the donor, recipient and follow-up care around each transplant.
What do the colours mean for this standard?
Red (Must) is required. Green (Medium) is recommended. Yellow (Minimum) is the lowest acceptable level in humanitarian settings. Standard setting is Must on every criterion.
Who must ask a donor family for consent?
Under 43.1 consent is obtained through a process that is independent of the transplant team requesting the organ.
How are organs allocated?
Under 43.2 allocation follows a written, transparent protocol based on clinical criteria, and any deviation is documented and justified.
Can a donor family be paid?
No. Under 43.3 no payment or material incentive is offered, beyond reimbursement of documented direct costs.
How are recipients chosen?
Under 43.4 recipients are evaluated against clinical eligibility criteria, and consent covers realistic outcomes, risks and the source of the organ or tissue.
Can an organ be traced?
Under 43.5 every organ or tissue is traceable through a documented chain of custody from donor to recipient, with no gap in the record.
Is follow-up tracked after transplant?
Under 43.6 recipients are followed systematically, and graft and patient outcomes are tracked and reported.
Guidelines for this standard
3 guideline(s) are held in the GMJ Guidelines Library and listed here. Each link opens the full guideline on news.gmj.ge. The complete library, grouped by standard, is at Guidelines.
- The Declaration of Istanbul on Organ Trafficking and Transplant Tourism (2018 Edition) (Declaration of Istanbul Custodian Group)
- Guiding Principles on Human Cell, Tissue and Organ Transplantation (World Health Organization)
- Guiding principles for prioritizing malaria interventions in resource-constrained country contexts to achieve maximum impact, 2nd ed. (World Health Organization)